tiprankstipranks
Trending News
More News >
Mega Genomics Limited (HK:6667)
:6667
Hong Kong Market
Advertisement

Mega Genomics Limited (6667) Ratios

Compare
0 Followers

Mega Genomics Limited Ratios

HK:6667's free cash flow for Q2 2024 was ¥0.65. For the 2024 fiscal year, HK:6667's free cash flow was decreased by ¥ and operating cash flow was ¥0.38. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
5.43 7.62 9.82 1.36 3.47
Quick Ratio
5.42 7.58 9.77 1.35 3.43
Cash Ratio
3.88 4.92 3.43 0.79 0.99
Solvency Ratio
0.24 -0.03 1.20 0.34 0.16
Operating Cash Flow Ratio
0.11 -0.09 0.44 0.39 0.70
Short-Term Operating Cash Flow Coverage
7.67 0.00 0.00 0.69 3.58
Net Current Asset Value
¥ 541.51M¥ 531.38M¥ 607.67M¥ 80.93M¥ -82.07M
Leverage Ratios
Debt-to-Assets Ratio
0.05 0.02 0.01 0.37 0.70
Debt-to-Equity Ratio
0.06 0.02 0.02 0.96 -68.04
Debt-to-Capital Ratio
0.06 0.02 0.02 0.49 1.01
Long-Term Debt-to-Capital Ratio
0.03 0.00 0.00 0.00 -55.29
Financial Leverage Ratio
1.26 1.14 1.11 2.57 -97.61
Debt Service Coverage Ratio
19.60 -2.25 14.44 0.66 2.11
Interest Coverage Ratio
0.00 3.51 15.37 6.68 3.28
Debt to Market Cap
0.01 0.00 0.00 0.04 <0.01
Interest Debt Per Share
0.20 0.06 0.15 0.78 0.85
Net Debt to EBITDA
-10.54 71.73 -1.95 -0.31 1.82
Profitability Margins
Gross Profit Margin
64.89%56.08%70.27%71.96%63.44%
EBIT Margin
37.79%-14.20%43.34%54.84%46.79%
EBITDA Margin
41.34%-3.72%49.19%61.75%58.15%
Operating Profit Margin
29.13%1.73%44.77%54.44%52.00%
Pretax Profit Margin
40.12%-14.70%40.42%46.70%30.96%
Net Profit Margin
34.46%-12.09%33.31%38.92%24.00%
Continuous Operations Profit Margin
34.46%-12.09%33.31%38.92%24.00%
Net Income Per EBT
85.89%82.26%82.41%83.35%77.54%
EBT Per EBIT
137.73%-847.57%90.29%85.79%59.53%
Return on Assets (ROA)
4.44%-2.50%10.23%17.44%11.26%
Return on Equity (ROE)
5.58%-2.85%11.38%44.84%-1098.85%
Return on Capital Employed (ROCE)
4.46%0.40%15.12%57.86%30.53%
Return on Invested Capital (ROIC)
3.81%0.33%12.35%26.40%21.94%
Return on Tangible Assets
4.45%-2.50%10.24%17.46%11.29%
Earnings Yield
2.68%-0.74%4.24%2.18%0.77%
Efficiency Ratios
Receivables Turnover
0.71 0.79 1.16 1.56 1.14
Payables Turnover
0.78 1.84 2.41 2.12 3.77
Inventory Turnover
31.21 18.25 21.47 19.17 18.53
Fixed Asset Turnover
1.23 2.93 4.47 3.25 1.64
Asset Turnover
0.13 0.21 0.31 0.45 0.47
Working Capital Turnover Ratio
0.19 0.25 0.67 1.79 0.00
Cash Conversion Cycle
55.78 284.72 179.22 80.73 241.87
Days of Sales Outstanding
511.60 462.92 313.36 233.91 319.04
Days of Inventory Outstanding
11.69 20.01 17.00 19.04 19.69
Days of Payables Outstanding
467.52 198.21 151.14 172.22 96.87
Operating Cycle
523.30 482.93 330.36 252.95 338.74
Cash Flow Ratios
Operating Cash Flow Per Share
0.07 -0.03 0.24 0.43 0.16
Free Cash Flow Per Share
0.07 -0.06 0.21 0.43 0.15
CapEx Per Share
<0.01 0.03 0.03 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.96 1.75 0.86 0.99 0.98
Dividend Paid and CapEx Coverage Ratio
24.19 -1.33 6.93 98.41 48.98
Capital Expenditure Coverage Ratio
24.19 -1.33 6.93 98.41 48.98
Operating Cash Flow Coverage Ratio
0.36 -0.63 2.65 0.61 0.20
Operating Cash Flow to Sales Ratio
0.14 -0.05 0.13 0.51 0.30
Free Cash Flow Yield
0.97%-0.51%1.40%2.81%0.95%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
37.34 -134.41 23.61 45.80 129.56
Price-to-Sales (P/S) Ratio
13.77 16.25 7.87 17.83 31.10
Price-to-Book (P/B) Ratio
2.08 3.83 2.69 20.54 -1.42K
Price-to-Free Cash Flow (P/FCF) Ratio
102.89 -195.72 71.19 35.59 105.36
Price-to-Operating Cash Flow Ratio
92.19 -342.65 60.91 35.23 103.21
Price-to-Earnings Growth (PEG) Ratio
5.23 1.18 0.27 0.26 0.00
Price-to-Fair Value
2.08 3.83 2.69 20.54 -1.42K
Enterprise Value Multiple
22.76 -365.10 14.04 28.56 55.30
Enterprise Value
1.01B 1.98B 1.64B 3.58B 3.98B
EV to EBITDA
22.76 -365.10 14.04 28.56 55.30
EV to Sales
9.41 13.58 6.91 17.64 32.16
EV to Free Cash Flow
70.32 -163.58 62.51 35.21 108.95
EV to Operating Cash Flow
67.41 -286.38 53.48 34.85 106.73
Tangible Book Value Per Share
3.16 2.99 5.45 0.73 -0.01
Shareholders’ Equity Per Share
3.16 3.00 5.46 0.74 -0.01
Tax and Other Ratios
Effective Tax Rate
0.14 0.18 0.18 0.17 0.22
Revenue Per Share
0.51 0.71 1.86 0.85 0.52
Net Income Per Share
0.18 -0.09 0.62 0.33 0.12
Tax Burden
0.86 0.82 0.82 0.83 0.78
Interest Burden
1.06 1.03 0.93 0.85 0.66
Research & Development to Revenue
0.09 0.13 0.05 0.02 0.04
SG&A to Revenue
0.16 0.29 0.01 <0.01 0.01
Stock-Based Compensation to Revenue
0.01 0.03 0.00 0.00 0.00
Income Quality
0.41 0.32 0.32 1.08 0.97
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis